← Scroll for more →
Bristol Myers Squibb Co (BMY)
Pharmaceutical Preparations
Latest Price
$62.40
TTM P/E
13.71
Normalized P/E
30.06
Div Yield
4.02%
Book Value
10.93
P/B Ratio
5.71
Valuation metrics
adjust assumptions →EPS: $3.46
Book value / share: $9.06
Formula: √(22.5 × EPS × BVPS)
Graham Number
$26.56
57% downside
Norm. op. income: $8.9B (median of 7yr)
Tax rate: 18%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$18.07
71% downside
Base FCF: $12.8B (median of recent 5yr)
Growth: 8%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$116.60
+87% upside
EPS: $3.46
Target P/E: 30×
Formula: EPS × P/E
P/E Fair Value
$103.80
+66% upside
Institutional Ownership
84.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 180.38M | $10.39B | 8.84% | +8.70M | 2026-06-30 |
| Vanguard Capital Management LLC | 133.34M | $7.68B | 6.54% | +1.02M | 2026-06-30 |
| State Street Corp | 102.41M | $5.90B | 5.02% | +3.84M | 2026-06-30 |
| JPMorgan Chase & Co | 71.71M | $4.20B | 3.52% | -3.65M | 2026-06-30 |
| Charles Schwab Investment Management Inc | 67.60M | $3.89B | 3.31% | +6.48M | 2026-06-30 |
| Sixth Street Partners Management Company, L.P. | 67.60M | $3.89B | 3.31% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 56.44M | $3.24B | 2.77% | +1.16M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 46.87M | $2.70B | 2.30% | +642.9K | 2026-06-30 |
| Norges Bank | 36.87M | $2.12B | 1.81% | +766.0K | 2026-06-30 |
| Bank of America Corp | 34.05M | $1.96B | 1.67% | +1.46M | 2026-06-30 |